TGFB1 and neoplasm: The results revealed that the combination of anti-TGF-β and nivolumab induced a significantly higher proportion of apoptotic tumor cells after 72 h of co-culture, while anti-TGF-β or nivolumab alone did not induce apoptosis of tumor cells compared with the isotype control (Fig. 5L).